• Non-respiratory revenue up 7% y/y on a supplemental combined basis QuidelOrtho – Proprietary & Confidential. | © 2023. All Rights Reserved. 8 • China strength was driven by the end of lockdowns Non-GAAP Financial Measures: This presentation contains financial measures, including but not limited to "constant currency" revenue changes, "adjusted net income," "adjusted diluted EPS," "adjusted EBITDA," "adjusted EBITDA margin," "supplemental combined adjusted net income," "supplemental combined adjusted dilut ...

February 15, 2023 QuidelOrtho Financial Results 4Q & FY 2022 © 2023. All Rights Reserved. 2 Forward-Looking Statements Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements in this presentation by words such as "may," "will," "would," "expect," "anticipate," "believe," "estimate," "plan," "intend," "continue" o ...

Andrew Brackmann Yeah. Hey, Andrew. We did go -- the $300 million to $500 million is still our range. So thatÂ's consistent and we can talk about the government contracts. But thatÂ's -- we are not treating that as normal and usual. [Inaudible] Joe Busky Hey, guys. Thank you for taking the questions. Hey, guys. Thanks for taking the question. I appreciate it. Yeah. Thanks, Conor. Joe Busky Oh! Eliza. Doug Bryant Okay. Makes total sense. And then I just wanted to get some clarification around the EBITDA to f ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 10-Q ____________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Co ...

QuidelOrtho Corporation (NASDAQ:QDEL) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Douglas Bryant - Chairman and CEO Joseph Busky - CFO Conference Call Participants Andrew Cooper - Raymond James Patrick Donnelly - Citi Andrew Brackmann - William Blair Alexander Nowak - Craig Hallum Casey Woodring - JP Morgan Operator Welcome to the QuidelOrtho Third Quarter 2022 Financial Results Conference Call and Webcast. At this ti ...

| --- | --- | |-----------------------------------|-------| | | | | | | | Forging the Future of Diagnostics | | | Financial Results 3Q 2022 | | Forward-Looking Statements Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this presentation by words such as "may," "will ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 10-Q ____________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commi ...

QuidelOrtho Corporation (NASDAQ:QDEL) Q2 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Douglas Bryant - Chairman and CEO Joseph Busky - CFO Conference Call Participants Jack Meehan - Nephron Research Andrew Cooper - Raymond James Casey Woodring - JP Morgan Alex Nowak - Craig Hallum Operator Welcome to the QuidelOrthoÂ's Second Quarter 2022 Financial Results Conference Call and Webcast. At this time, all participants lines are in ...

| --- | |-------| | | | | | | | | Forward-Looking Statements Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this presentation by words such as "may," "will," "would," "expect," "anticipate," "believe," "estimate," "plan," "intend," "continue," or similar words, exp ...

Ortho Clinical Diagnostics Holdings PLC (OCDX) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Chris Smith - Chairman and Chief Executive Officer Joseph Busky - Chief Financial Officer Operator Welcome to the Ortho Clinical Diagnostics First Quarter 2022 Earnings Conference Call and Webcast. At this time, all participants lines are in a listen-only mode. Please note this conference is being recorded. An audio replay of the con ...